UCSF Helen Diller Family Comprehensive Cancer Center
Announcements 4/15/2015
of interest to the UCSF cancer community

view online  |  corrections  |  unsubscribe  |  follow us on Twitter   

In Memorium

We are saddened to report the sudden passing of former HDFCCC Member Dr. Andrew Parsa on Monday, April 13. Dr. Parsa served as the Khatib Chair in Skull Base Tumor Surgery and was an active member of the cancer community at UCSF, a member of both the Neurological Oncology and Cancer Immunity research programs at HDFCCC, as well as principal investigator at the Brain Tumor Research Center. He left UCSF in 2013.
from the Chicago Tribune: "Known for his research on brain tumor immunology, Dr. Parsa joined Feinberg in 2013 after serving as a professor and vice chairman of the Department of Neurological Surgery at the University of California at San Francisco, where he led an innovative approach to treating brain cancer by removing patients' tumors and creating individual vaccines from their malignant masses." >Read more

Featured events

HDFCCC Programmatic Events

Special Fundraiser

ABC News Tweet Chat Opportunity with AACR

ABC News Twitter Chat on Breakthroughs in Cancer Research at the AACR Annual Meeting, 4/21
Faculty: Please let me know if you are interested in participating in this national conversation about cancer research in conjunction with the AACR annual meeting via Twitter Tues. April 21, 10 a.m. PST. Looks like a great opportunity.

> Read more
> Email if you are interested

Funding Opportunities

Special Announcement:   LOI for CCSG 2015 LMIC Supplement - Due 4/24

The National Cancer Institute (NCI), through its Center for Global Health (CGH), seeks to promote cancer prevention and control (CPC) research in low- and middle-income countries (LMICs) through collaborations and research partnerships between the NCI-designated cancer centers and partner institutions in LMICs. Through PAR-15-155, the NCI will provide administrative supplement awards to currently funded P30 NCI-designated cancer center grantees to support pilot research plans that focus on cancer prevention and control. These supplements are designed to stimulate and strengthen CPC twinning programs between researchers at the NCI-designated cancer centers and institutions in LMICs. It is anticipated that outcomes of this supplement will include collaborative research grants between investigators at the NCI-designated cancer centers and LMIC institutions.


Please see the following for additional information about this funding opportunity:

To gauge interest in this opportunity at the HDFCCC, all interested applicants must complete the following LOI: The LOI is due on Friday, April 24th.

Email this LOI and any questions to Erin Bank.

Current Limited Submission Opportunities (Applications through LSO office)


UCSF-HDFCCC Karen Gehrman, Communications
415.476.5438 (voice) | communications@cc.ucsf.edu